Role of Tumor Specific niche in Colon Cancer Progression and Emerging Therapies by Targeting Tumor Microenvironment
- PMID: 30969400
- DOI: 10.1007/5584_2019_355
Role of Tumor Specific niche in Colon Cancer Progression and Emerging Therapies by Targeting Tumor Microenvironment
Abstract
Colorectal cancer is the third most common form of cancer worldwide leading to escalating mortality rates and mainly includes hereditary, sporadic and colitis-associated cancer development. The escalated mortality rates is due to the limited treatment options as this form of cancer is usually not easy to diagnose in its early stages and are highly invasive leading to rapid metastasis of the malignant cells to the neighbouring tissue. In order to combat this limitation several chemotherapeutic regimens are now being combined with targeted therapies after the knowledge acquired on the inevitable effects of the tumor microenvironment on the colon cancer growth and progress. The colon tumor niche mainly consists of a large mass of tumor cells along with various immune cells, inflammatory cells, tumor macrophages and fibroblasts that infiltrate the tumor as it is a site of predominant inflammation. Among cells of the microenvironment, mesenchymal stem cells (MSCs) exhibiting ability to evolve into cancer associated fibroblasts (CAFs) have recently generated a major interest in the field. The physiological state of the tumor microenvironment is closely connected to discrete steps of tumorigenesis. The colon cancer cells elicit various factors with their direct interaction with MSCs or via paracrine fashion, which modulate these cells to promote cancer instead of performing their innate function of abating cancer progression. This review intends to highlight the necessity to exploit the cellular landscape of tumor microenvironment of colon cancer and a detailed understanding of the interactions between tumor epithelial cells and their stromal/inflammatory elements will aid in future perspectives for designing therapeutic regimens targeting tumor microenvironment to improve the clinical outcome of colon cancer.
Keywords: Colon cancer; Cytokines; Mesenchymal stem cells; Metastasis; Targeted therapy; Tumor niche; microRNAs.
© 2019. Springer Nature Switzerland AG.
Similar articles
-
Bone marrow mesenchymal stem cells in microenvironment transform into cancer-associated fibroblasts to promote the progression of B-cell acute lymphoblastic leukemia.Biomed Pharmacother. 2020 Oct;130:110610. doi: 10.1016/j.biopha.2020.110610. Epub 2020 Aug 12. Biomed Pharmacother. 2020. PMID: 34321159
-
Multikinase inhibitor regorafenib inhibits the growth and metastasis of colon cancer with abundant stroma.Cancer Sci. 2016 May;107(5):601-8. doi: 10.1111/cas.12907. Epub 2016 Mar 18. Cancer Sci. 2016. PMID: 26865419 Free PMC article.
-
Recent discoveries concerning the tumor - mesenchymal stem cell interactions.Biochim Biophys Acta. 2016 Dec;1866(2):290-299. doi: 10.1016/j.bbcan.2016.10.004. Epub 2016 Oct 14. Biochim Biophys Acta. 2016. PMID: 27750042 Review.
-
Mesenchymal stromal cells (MSCs) and colorectal cancer: a troublesome twosome for the anti-tumour immune response?Oncotarget. 2016 Sep 13;7(37):60752-60774. doi: 10.18632/oncotarget.11354. Oncotarget. 2016. PMID: 27542276 Free PMC article. Review.
-
Glioblastoma-Associated Mesenchymal Stem/Stromal Cells and Cancer-Associated Fibroblasts: Partners in Crime?Int J Mol Sci. 2024 Feb 14;25(4):2285. doi: 10.3390/ijms25042285. Int J Mol Sci. 2024. PMID: 38396962 Free PMC article. Review.
Cited by
-
Tumor Progression from a Fibroblast Activation Protein Perspective: Novel Diagnostic and Therapeutic Scenarios for Colorectal Cancer.Diagnostics (Basel). 2023 Oct 13;13(20):3199. doi: 10.3390/diagnostics13203199. Diagnostics (Basel). 2023. PMID: 37892020 Free PMC article.
-
Role of Interleukins in Inflammation-Mediated Tumor Immune Microenvironment Modulation in Colorectal Cancer Pathogenesis.Dig Dis Sci. 2023 Aug;68(8):3220-3236. doi: 10.1007/s10620-023-07972-8. Epub 2023 Jun 5. Dig Dis Sci. 2023. PMID: 37277647 Review.
-
From the Catastrophic Objective Irreproducibility of Cancer Research and Unavoidable Failures of Molecular Targeted Therapies to the Sparkling Hope of Supramolecular Targeted Strategies.Int J Mol Sci. 2023 Feb 1;24(3):2796. doi: 10.3390/ijms24032796. Int J Mol Sci. 2023. PMID: 36769134 Free PMC article. Review.
-
Identification of a prognostic model based on costimulatory molecule-related subtypes and characterization of tumor microenvironment infiltration in acute myeloid leukemia.Front Genet. 2022 Aug 19;13:973319. doi: 10.3389/fgene.2022.973319. eCollection 2022. Front Genet. 2022. PMID: 36061194 Free PMC article.
-
Texture Features of Computed Tomography Image under the Artificial Intelligence Algorithm and Its Predictive Value for Colorectal Liver Metastasis.Contrast Media Mol Imaging. 2022 Jul 19;2022:2279018. doi: 10.1155/2022/2279018. eCollection 2022. Contrast Media Mol Imaging. 2022. PMID: 35935311 Free PMC article. Clinical Trial.
References
-
- Ali S, Dubaybo H, Brand RE, Sarkar FH (2015b) Differential expression of microRNAs in tissues and plasma co-exists as a biomarker for pancreatic cancer. J Cancer Sci Ther 7(11):336 - DOI
-
- Bahrami A, Khazaei M, Hassanian SM et al (2018) Targeting the tumor microenvironment as a potential therapeutic approach in colorectal cancer: rational and progress. J Cell Physiol 233(4):2928–2936 - DOI
-
- Balkwill FR, Capasso M, Hagemann T (2012) The tumor microenvironment at a glance. J Cell Sci 125(Pt 23):5591–5596 - DOI
-
- Bullock MD, Pickard KM, Nielsen BS et al (2013) Pleiotropic actions of miR-21 highlights the critical role of deregulated stromal microRNAs during colorectal cancer progression. Cell Death Dis 4(6):e684 - DOI
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
